Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.32 USD | +0.85% | +0.91% | +2.16% |
04-15 | Morgan Stanley Raises Price Target on Aflac to $84 From $80, Maintains Equalweight Rating | MT |
04-11 | Wells Fargo Cuts Price Target on Aflac to $81 From $83, Keeps Equalweight Rating | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is highly valued given the cash flows generated by its activity.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.16% | 48.11B | B | ||
+15.94% | 79.51B | B- | ||
+8.06% | 50.22B | B+ | ||
+9.84% | 42.2B | B+ | ||
+7.65% | 39.71B | B+ | ||
+20.02% | 37.78B | B | ||
+2.37% | 30.07B | B | ||
-7.58% | 27.56B | B- | ||
-16.43% | 24.71B | A- | ||
+11.04% | 21.99B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AFL Stock
- Ratings Aflac Incorporated